April 16, 2026

Best Health Ideas

Every Health & Fitness Helps

Startup radar: Europe’s healthtech startups to look at

Startup radar: Europe’s healthtech startups to look at
Undertaking money offer activity in European healthtech has slowed considering the fact that the pandemic, but the sector continues to be a major draw for buyers in the location.

When 2021 represented a peak in financial commitment activity—with €5.2 billion (about $5.6 billion) invested across 906 healthtech startups—nearly €5 billion was however invested very last year, according to PitchBook info. Meanwhile, this calendar year, we have previously witnessed 40 European startups in the sector catch the attention of €232.6 million in new capital.

“Evidently we are not in 2021 any longer, but innovation in [healthtech] carries on to speed up,” John E. Milad, husband or wife and co-head of health care ventures at expense supervisor Downing, mentioned. “There are tremendous difficulties that will need to be addressed which will not go absent just because there is certainly a downturn. It will be additional difficult for startups heading ahead, but the essential want is nevertheless there.”

We asked six VCs active in European healthtech to share two startups—one in their portfolio, just one not—that they are thrilled about.

John E. Milad and Nigel Pitchford
Associates and co-heads of healthcare ventures, Downing (London)

Cydar Medical (United kingdom)

Pitchford: “Cydar is a surgical augmented intelligence company that offers authentic-time imaging to aid surgeons approach and execute surgeries in a much much more expeditious way. It decreases the time used in the functioning home, the selection of surgical issues and X-ray publicity for sufferers.

“The corporation has already obtained traction and partnerships in spot with organizations like Phillips. It has the possible to lower time and costs of surgical treatment and thus boosts obtain for patients.”

Otivio (Norway)

Milad: “Otivio have produced a professional medical unit for a number of sclerosis that has the prospective to truly thrust the needle in an location of big unmet will need. There are almost 3 million individuals struggling from this sickness and there are not really any fantastic therapies to deal with it.

“Otivio’s system was initially meant to treat vascular disorder but in a examine discovered that some people with MS suddenly had aid from what were being normally debilitating signs. They have published some promising but not still thoroughly conclusive clinical facts which is suggesting that their gadget could be genuinely a major breakthrough treatment.”

Marta-Gaia Zanchi
Founder and handling companion, Nina Cash (Barcelona)

Zetta Genomics (Uk)

“Zetta Genomics has produced a info management method made particularly for the genomic age. Latest interrogation and examination instruments are not suitable for genomic facts of fashionable-day’s magnitude. Today, interpretation and examination pipelines are gradual, guide and highly-priced as info is stored in countless numbers of static, fragmented text files—meaning, current pipelines will not be ready to scale to accommodate the exponential prospective of genomic medicine.

“Zetta enables speedy access, interpretation and interrogation of genomic details, unlocking the possible to determine disease much more correctly, intervene previously and produce a lot more helpful and less invasive remedies. There is just no computer software method like it everywhere in the world—and Zetta’s buyers and partners on two continents are taking see.”

Daye (United kingdom)

“Daye puts the highlight on a drastically underserved place of requires and population by reimagining the tampon and doing work towards a potent eyesight for a detailed vaginal health platform.

“We fulfilled the enterprise when they were previously elevating a Collection A round, and this was a stretch for our preseed/seed emphasis. We at Nina Capital have appeared at nicely above 100 women’s wellbeing businesses in 2022 alone, and Daye stands out as it is developed on a real want and has the right ingredients vital to develop a powerful movement and reputable natural expansion motor in the potential.”

Lucanus Polagnoli
Founder and taking care of associate, Quiet/Storm Ventures (Vienna)

Mindstep (United kingdom)

“Mindstep provides individualized cognitive treatment to help decreased the chance of dementia by giving in-application treatment that incorporates each day brain stimulation tasks and a customized direction for taking care of recognized danger factors when at the similar time collecting a breadth of data that can be applied to capture the sickness at its early stage and acquire new medications to heal it.

“Dementia is a devastating and highly-priced ailment that is also likely to become much more common as our modern society ages. Twelve p.c of persons aged 70 are expected to get it with this amount rising to 22% for people above 80. There is at this time no get rid of for dementia, but its risk components can be minimized, proficiently reducing the chance of the disease developing. We believe that Mindstep is one to glance out for this calendar year and further than: an excellent crew that created a wonderful remedy for a hugely appropriate difficulty.”

Meela (Sweden)

“Meela is the Tinder concerning therapists and individuals. It makes it possible for feminine individuals to conserve time and work, get the right enable and make sure excellent assurance. On the offer facet of the market, therapists can make a lot more income with sticky consumers, streamline their capacities and admin duties and become improved at their work as a result of monitoring of medical details.

“Mental healthcare is broken. Far more than 50% of people starting therapy fall out just before session 3 because of a very poor therapist-affected individual match. Meela’s fall-out price right before session 3 is 2%. When there are certainly a handful of rivals in this area, we consider Meela is uniquely positioned to do well in the current market. Female founders making a psychological wellness item for gals offers them a massive edge on group building and commercials, making on currently 200-furthermore shelling out therapists on their system.”

Molly Gilmartin
Investment Supervisor, AlbionVC (London)

uMed (Uk)

“uMed has the skill to construct health care evidence in times, instead than yrs. It does so by connecting sufferers and their professional medical data with study companies in a privacy-compliant way.

“Longitudinal study can be really important to analysis companies, but is pretty high-priced. uMed’s technological innovation permits it at a portion of the charge as it automates numerous of the processes and info selection. Outside of longitudinal analysis, there are a lot of additional use situations for uMed’s technological know-how, from current market entry to unbiased demo recruitment to overall health outcomes assessments.”

Molecule (Germany)

“As a person of the most well-funded companies in the decentralized science (DeSci) area, Molecule will unquestionably be one particular to view in phrases of how it commences to fix some of the greatest operational troubles in a decentralized strategy to exploration.

“The workforce have built the first biotech DAO (decentralized autonomous business) and led the generation of the infrastructure driving the IP-NFT framework, and it will be appealing to see how experts and individuals engage in this analysis as it grows.

“The Molecule group have an awesome advisory board which will support the issue fixing of some of the unanswered questions for DeSci close to lawful, regulatory hurdles and there is no question this a founding crew that is passionate about building a new method and infrastructure for investigation and improvement.”

Catherine Boule
Managing husband or wife, Karista (Paris)

Incepto Clinical (France)

“Incepto Medical is an AI-primarily based SaaS system for clinical imaging, editing and distributing clinically validated programs based mostly on AI that offers productivity and decision help tools to radiologists.

“By now [a] leader on the French sector, Incepto has just lifted a Collection B to pursue its growth in European marketplaces. It has really excellent professional traction and a exceptional positioning of imaging applications integrator and distributor.”

Leuko (Spain)

“Leuko is a startup acquiring PointCheck, a linked gadget that can keep an eye on white blood cells non-invasively. White blood cells [are a] to start with-line indicator in quite a few conditions, ranging from cancer chemotherapy to infections. Its gadget is a really outstanding, small linked transportable device to examine the blood cells stage by imaging the blood flowing nevertheless capillaries in fingers.”

Highlighted picture by Tetra Illustrations or photos/Getty Pictures